Black Hawk Acquisition Corporation Reports Decrease in Net Income and Revenue, Plans Business Combination with Vesicor Therapeutics

Black Hawk Acquisition Corporation has reported its financial results for the three months ending February 28, 2026, revealing a net income of $139,805, a decrease from $658,379 in the same period the previous year. The company’s revenue primarily stems from interest income, which totaled $213,442, down from $765,911 year-over-year. General and administrative expenses significantly decreased to $24,189 from $78,769, contributing to the overall reduction in losses from operations, which improved to a loss of $54,189 compared to a loss of $108,769 in the prior year.

The company’s total assets increased to $24.82 million as of February 28, 2026, up from $23.88 million at the end of November 2025. This growth was primarily driven by an increase in cash and investments held in the Trust Account, which rose to $24.64 million from $23.83 million. However, total liabilities also increased to $4.70 million from $3.90 million, largely due to an increase in amounts due to the target company and related parties. The company reported a working capital deficit of $2.11 million, raising concerns about its liquidity and ability to continue as a going concern.

Strategically, Black Hawk is in the process of completing a business combination with Vesicor Therapeutics, Inc., a biotechnology firm focused on cancer therapeutics. The transaction, valued at a pre-money equity value of $70 million, is subject to regulatory approvals and shareholder votes. The company has also extended its business combination deadline to December 22, 2026, allowing for additional time to finalize the merger. As of February 28, 2026, the company had 2,124,077 public ordinary shares outstanding, following the redemption of approximately 4.78 million shares during its Extraordinary General Meeting in July 2025.

Operationally, Black Hawk has not yet commenced any revenue-generating activities, as it remains focused on identifying a suitable target for its business combination. The company has incurred significant costs related to its public company status and the ongoing search for a merger partner. Management has indicated that it expects to continue facing challenges in securing additional capital to meet its liquidity needs, which may impact its ability to complete the proposed business combination.

Looking ahead, Black Hawk's management has expressed uncertainty regarding the completion of the business combination within the designated timeframe. The company’s ability to continue as a going concern is contingent upon successfully executing the merger and generating operational revenues thereafter. The financial statements reflect this uncertainty, as they do not include adjustments that might result from the outcome of these conditions. The company remains committed to pursuing its strategic objectives while navigating the complexities of the current market environment.